Senate Health Committee Chair Sanders Announces Generic Pharma Companies Willing to Sell Ozempic for Less Than $100
September 18, 2024
September 18, 2024
WASHINGTON, Sept. 18 -- Sen. Bernie Sanders, I-Vermont, chair of the Senate Health, Education, Labor and Pensions Committee, issued the following news release on Sept. 17, 2024:
Ahead of next week's hearing with Novo Nordisk CEO Lars Jorgensen, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions Committee (HELP), today announced that CEOs of major generic pharmaceutical companies are willing to sell Ozempic to Americans for less than $100 per m . . .
Ahead of next week's hearing with Novo Nordisk CEO Lars Jorgensen, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions Committee (HELP), today announced that CEOs of major generic pharmaceutical companies are willing to sell Ozempic to Americans for less than $100 per m . . .